Schizophrenia Research
Volume 77, Issue 2 , Pages 253-260, 15 September 2005

Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment

Preliminary data for three of the polymorphisms was presented as an abstract at the 2004 College of Psychiatric and Neurologic Pharmacists (CPNP) meeting in Chicago, IL April 9–11, 2004.

  • Jeffrey R. Bishop

      Affiliations

    • University of Iowa College of Pharmacy, Clinical and Administrative Division, S413 Pharmacy Building, Iowa City, IA 52242, USA
    • ,
  • Vicki L. Ellingrod

      Affiliations

    • University of Iowa College of Pharmacy, Clinical and Administrative Division, S413 Pharmacy Building, Iowa City, IA 52242, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 319 335 8837; fax: +1 319 353 5646.
    • ,
  • Jessica Moline

      Affiliations

    • University of Iowa College of Pharmacy, Clinical and Administrative Division, S413 Pharmacy Building, Iowa City, IA 52242, USA
    • ,
  • Del Miller

      Affiliations

    • University of Iowa Carver College of Medicine Department of Psychiatry, USA

Received 28 January 2005; received in revised form 24 March 2005; accepted 4 April 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-9964(05)00135-0

doi:10.1016/j.schres.2005.04.001

Schizophrenia Research
Volume 77, Issue 2 , Pages 253-260, 15 September 2005

Article Tools